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Abstract We isolated a constitutively active form of cGMP-
dependent protein kinase IK (cGK IK) by PCR-driven random
mutagenesis. The replacement of Ile-63 by Thr in the auto-
inhibitory domain results in the enhancement of autophosphor-
ylation and the basal kinase activity in the absence of cGMP.
The hydrophobicity at position 63 is essential for the inactive
state of cGK IK, and Ile-78 of cGK IL is also required for the
autoinhibitory property. Furthermore, cGK IK (Ile-63-Thr) is
constitutively active in vivo. These findings suggest that a
conserved residue in the autoinhibitory domain was involved in
the autoinhibition of both cGK Is.
z 2000 Federation of European Biochemical Societies.
1. Introduction
An increase in intracellular cGMP levels results in smooth
muscle relaxation, platelet aggregation, intestinal secretion
and endochondral ossi¢cation mediated through the activa-
tion of cGMP-dependent protein kinases (cGKs) [1^3]. Two
major isoforms of cGK, termed cGK I and cGK II, were
identi¢ed to be encoded by distinct genes, and cGK I has
two isoforms, designated IK and IL, produced by alternative
mRNA splicing [4]. cGK IK and cGK IL were demonstrated
to be dimeric enzymes that contain several domains with well
de¢ned functions. The regulatory compartment located in the
N-terminal region contains the leucine zipper motif, multiple
autophosphorylation sites and an autoinhibitory domain, fol-
lowed by two cGMP-binding and catalytic domains [5,6]. The
primary structure of the two alternative isoforms di¡ers only
in the N-terminal V100 residues, sharing 36% identity in this
region. While removal of the leucine zipper motif along with
the autoinhibitory region (residues 1^93) of cGK IL results in
a monomeric and constitutively active enzyme [5], cGK IL
lacking the leucine zipper motif (residues 1^61) is still acti-
vated in the presence of cGMP [7]. Both cGK IK and IL
are supposed to contain substrate sites and a putative pseu-
dosubstrate sequence within their autoinhibitory domain, sug-
gesting that these regions interact with the catalytic site and
inhibit phosphotransferase activity in the absence of cGMP.
In cAMP-dependent protein kinase (cAK), two tandem basic
amino acids in the autoinhibitory region are important for
recognition as the consensus phosphorylation sequence and
for potent inhibition of the catalytic subunit of cAK by the
regulatory subunit [8]. S.H. Francis and colleagues have dem-
onstrated that Arg-75 at the pseudosubstrate site of cGK IL is
required for autoinhibition [9], and that the level of phosphor-
ylation of Ser-79 located within this sequence signi¢cantly
increases in the presence of cGMP and correlates with an
increase in basal kinase activity [10]. In fact, a recent study
on the pseudosubstrate sequence of cGK IL showed that re-
placement of Arg-75 by Ala, or of Ser-79 by an acidic residue,
aspartic acid, to mimic the e¡ect of autophosphorylation,
generates strong basal kinase activity [11]. However, this basic
residue Arg-75 is replaced by Ala in the pseudosubstrate se-
quence 59RAQGISAEP of the cGK IK, and Ser-64 in cGK IK
corresponding to Ser-79 is reported to be only a minor phos-
phoacceptor site [12]. Thus, the amino acid residue responsi-
ble for autoinhibition of cGK IK is less well understood. To
determine the amino acid residues critical for autoinhibition
and function of this enzyme, the N-terminal sequence of cGK
IK was subjected to PCR-driven random mutagenesis. Here,
we isolated a constitutively active enzyme of cGK IK, and
identi¢ed a conserved residue in the autoinhibitory domain,
which was involved in the autoinhibitory mechanism of both
cGK IK and cGK IL.
2. Materials and methods
2.1. Materials
Restriction endonucleases and DNA-modifying enzymes were pur-
chased from Takara Shuzo (Kyoto, Japan). COS-7 cells were from
Dainippon Pharmaceutical (Osaka, Japan). Dulbecco’s modi¢ed Ea-
gle’s medium (DMEM) and fetal bovine serum (FCS) were obtained
from Life Technologies. [Q-32P]ATP was a product of Amersham
Pharmacia Biotech.
2.2. Plasmid construction
The full-length bovine cGK IK cDNA was a gift from Dr. Thomas
M. Lincoln (The University of Alabama at Birmingham). A cDNA
encoding full-length cGK IK was subcloned into the EcoRI and KpnI
sites of the expression vector pFLAG-CMV-2 (Kodak) fused in frame
with the epitope sequence for anti-FLAG antibody (pFLAG-cGK
IK). The cDNA clone that encodes the full-length human cardiac
troponin I (cTnI) was provided by Dr. Yuichiro Maeda, and sub-
cloned into the NotI site of the expression vector pFLAG-CMV-2.
To introduce random mutations in cGK IK sequence, a PCR was run
for 35 cycles (1 min at 94‡C, 2 min at 50‡C and 3 min at 72‡C) under
standard conditions using a set of PCR primers (5P-AAACATGAGC-
GAGCTGGAGGAAGAC-3P, 5P-CCCTGAGAATGGTCCAGAGC-
TCTCCAC-3P) and the full-length bovine cGK IK cDNA as a temper-
ate, and the PCR products were digested with EcoRI and MluI.
Excised 1.1 kb cDNAs harboring the PCR-generated mutations
were ligated into EcoRI and MluI sites of the pFLAG-cGK IK. The
full-length human cGK IL cDNA was obtained by standard PCR
protocol, and subcloned into pFLAG-CMV-2 as we described previ-
ously [13]. Site-directed mutagenesis was performed using Quick-
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change1 site-directed mutagenesis kit (Stratagene) according to the
protocol of the manufacturer. In each case, the mutation was con-
¢rmed by DNA sequencing analysis.
2.3. In vitro kinase assay
COS-7 cells were cultured in DMEM supplemented with 10% FCS,
100 U/ml penicillin and 100 mg/ml streptomycin at 37‡C in 5% CO2.
The full-length bovine cGK IK or human cGK IL cDNA, and the full-
length human cTnI cDNA in the expression vector pFLAG-CMV-2
were transiently expressed in COS-7 cells [13] using LipofectAMINE
PLUS according to the manufacturer’s instructions (Life Technolo-
gies). Cells were washed with ice-cold phophate-bu¡ered saline 24 h
after transfection, and scraped in an ice-cold TNE bu¡er (10 mM
Tris^HCl at pH 7.5, 1% NP40, 0.15 M NaCl, 1 mM EDTA, 10
mg/ml aprotinin, 10 mM leupeptin and 1 mM dithiothreitol). Cell
extracts were centrifuged at 16 000Ug for 15 min at 4‡C to remove
cellular debris. The supernatants were immunoprecipitated with anti-
FLAG M5 monoclonal antibody (Kodak) with protein G-Sepharose
overnight at 4‡C by rotation. The beads were washed ¢ve times with
TNE bu¡er. The in vitro kinase reaction was performed in kinase
reaction bu¡er (50 mM Tris^HCl at pH 7.5, 20 mM magnesium
acetate, 0.2 mM [Q-32P]ATP, 2 WM protein kinase A inhibitor (5-24)
(PKI (5-24), Calbiochem), 5 mM glycerophosphoric acid and 1 mM
sodium orthovanadate) in the presence or absence of cGMP (5 WM
¢nal concentration). The samples were incubated at 30‡C for 30 min
and centrifuged at 16 000Ug and 4‡C. The beads were mixed with an
equal volume of 2Usodium dodecyl sulfate (SDS) sample bu¡er and
heated at 95‡C for 5 min, and the denatured proteins were subjected
to SDS^polyacrylamide gel electrophoresis (PAGE). In order to eval-
uate the relative cGK I-dependent kinase activity in the presence and
absence of cGMP, in vitro kinase reaction was performed in kinase
reaction bu¡er using the synthetic peptide BPDEtide (Calbiochem) as
a substrate. The values were corrected relative to the kinase activity of
wild-type cGK IK in the absence of cGMP taken as one, and are
expressed as the mean of three independent experiments. For the
immunoblotting analysis, the proteins separated by SDS^PAGE
were transferred onto polyvinylidene di£uoride membranes (Milli-
pore). After being blocked with Block Ace (Snow Brand Milk Prod-
ucts) overnight, the membrane was incubated with anti-FLAG M5
monoclonal antibody for 2 h at room temperature. Bound primary
antibody was detected using horseradish peroxidase-conjugated anti-
mouse IgG (Sigma) and visualized by the ECL Western blotting de-
tection system (Amersham Pharmacia Biotech).
2.4. In vivo kinase assay
COS-7 cells were co-transfected with pFLAG-cGK IK and pFLAG-
cTnI as described above. For [32P]phosphate labeling, transiently
transfected COS-7 cells were washed and preincubated with phos-
phate-free medium containing 1 mCi/ml [32P]phosphate (500 WCi/ml,
NEN Life Science Products) for 3 h, and either left untreated or
treated with 8-(4-chlorophenylthio) guanosine-3P,5P-monophosphate
(8-CPT-cGMP, Sigma) for 30 min. Cells were scraped in an ice-cold
cell extract bu¡er (10 mM Tris^HCl at pH 7.5, 0.1% Triton X-100,
0.15 M NaCl, 1 mM EDTA, 10 mg/ml aprotinin, 10 mM leupeptin,
5 mM glycerophosphoric acid and 1 mM sodium orthovanadate). The
cell extracts were centrifuged at 16 000Ug for 15 min at 4‡C to re-
move cellular debris, and the supernatants were immunoprecipitated
with anti-FLAG M5 monoclonal antibody with protein G-Sepharose
for 4 h at 4‡C by rotation. The beads were washed twice with cell
extract bu¡er, and immune complexes were eluted by heating at 95‡C
in 2USDS sample bu¡er, subjected to SDS^PAGE and autoradio-
graphed at 380‡C.
3. Results
We attempted to isolate constitutively active forms of cGK
IK by PCR-mediated mutagenesis [14]. The mutated FLAG-
tagged cGK IK were expressed in COS-7 cells, and immuno-
precipitates were subjected to a kinase assay using FLAG-
tagged cTnI as a substrate. We isolated one clone (HM clone)
showing enhanced basal kinase activity and autophosphoryla-
tion in the absence of cGMP. Sequence analysis revealed two
point mutations, Arg-17CGly (R17G) and Ile-63CThr
(I63T), in the N-terminal region of the cGK IK sequence.
To clarify which of these mutations was responsible for the
constitutive activation, we constructed single mutants (cGK
IK (R17G) and cGK IK (I63T)), and investigated their kinase
activity. Replacement of Arg-17 by Gly did not alter the basal
activity of cGK IK (data not shown), whereas replacement of
Ile-63 by Thr generated signi¢cant increases in the level of
basal kinase activity and autophosphorylation when com-
pared with wild-type cGK IK (Fig. 1). The protein expression
level of the constitutively active mutant was similar to that of
wild-type cGK IK (Fig. 1). Next, we tested the e¡ects of sev-
eral other amino acids substituted for Ile-63 on the basal
kinase activity. The e¡ects of these mutants were tested by
measuring the basal and cGMP-activated kinase activities us-
ing BPDEtide, as a substrate. The protein expression levels of
these mutants were similar to that of wild-type cGK IK (data
Fig. 1. Phosphorylation of cTnI by cGK IK in vitro. COS-7 cells
were transfected with the expression plasmid for FLAG-cTnI.
Where indicated, plasmid expressing either FLAG-cGK IK or
FLAG-cGK IK (I63T) was included in the transfection. Whole cell
lysates were immunoprecipitated with anti-FLAG antibody (IP:
Flag), and cGK activity was measured in an in vitro kinase assay.
Reactions were performed in the absence (3) or presence (+) of
5 WM cGMP. To monitor the expression level of each kinase, the
immunoprecipitates were blotted with anti-FLAG antibody (Blot:
Flag).
Table 1
Phosphorylation of BPDEtide by cGK IK in vitro
Relative kinase activity Ratio (plus/minus
of cGMP)
cGMP minus cGMP plus
IK I (WT) 1.00 5.98 þ 0.01 5.98
G 2.85 þ 0.21 3.65 þ 0.19 1.28
A 1.80 þ 0.17 3.80 þ 0.05 2.11
T 1.92 þ 0.07 3.93 þ 0.21 2.05
S 3.16 þ 0.21 3.48 þ 0.20 1.10
L 0.86 þ 0.07 2.62 þ 0.06 3.06
F 0.88 þ 0.04 4.49 þ 0.03 5.08
V 0.92 þ 0.14 6.00 þ 0.23 6.53
IL I (WT) 0.22 þ 0.03 2.95 þ 0.07 13.72
G 1.40 þ 0.04 2.46 þ 0.09 1.76
The e¡ects of several other amino acids substituted for Ile-63 on
the basal kinase activity were tested by measuring the basal and
cGMP-activated kinase activities using BPDEtide, as a substrate.
COS-7 cells were transfected with each expression plasmid for
FLAG-cGK IK. Whole cell lysates were immunoprecipitated with
anti-FLAG antibody, and subjected to an in vitro kinase assay. Re-
actions were performed in the absence (minus) or presence (plus) of
5 WM cGMP.
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not shown). Substitution of Ile-63 by Gly, Ala or Ser in-
creased the basal kinase activity, being accompanied by a
relatively low ratio of kinase activity in the presence and ab-
sence of cGMP. Interestingly, replacement of Ile-63 by hydro-
phobic residues such as Phe or Val resulted in a similar enzy-
matic property as to that of the wild-type cGK IK with
increases in kinase activity of 5.1- and 6.5-fold, respectively
(Table 1). Furthermore, immunocytochemical studies revealed
that cGK IK (I63T) localized to cytoplasm but not to the
nucleus in the presence and absence of cGMP (data not
shown), being consistent with recent observations by S.P. Col-
lins et al. [11].
Both cGK IK and cGK IL contain putative pseudosubstrate
sites in their autoinhibitory regions. The pseudosubstrate site
resembling the consensus phosphorylation sequence is sup-
posed to play an important role in the interaction between
the autoinhibitory and catalytic regions. The pseudosubstrate
sites of cGK IK and cGK IL are 59RAQGISAEP and
74KRQAISAEP, respectively. Because the Ile-63 in cGK IK
is conserved in cGK IL at position 78, we constructed the
same mutant of cGK IL (I78G). Similarly, we transfected
cGK IL (I78G) into COS-7 cells, and subjected the immuno-
complex to in vitro kinase assay. As we expected, the replace-
ment of Ile-78 by Gly results in an upregulation of autophos-
phorylation and basal kinase activity in the absence of cGMP
(Fig. 2), indicating that cGK IL (I78G) is a constitutively
active mutant.
Next, to determine whether cGK IK (I63T) is constitutively
active in intact cells, cGK IK and cTnI were co-expressed as
FLAG-tagged proteins in COS-7 cells. After 32P-labeling, the
cells were untreated or treated with a membrane-permeable
cGMP analogue, 8-CPT-cGMP. Immunoprecipitation by us-
ing anti-Flag antibody showed that cTnI was signi¢cantly
phosphorylated by cGK IK (I63T) in the absence of 8-CPT-
cGMP (Fig. 3). A kinase-defective mutant of cGK IK, cGK
IK (D501A), did not catalyze the phosphorylation of cTnI,
con¢rming that cTnI is phosphorylated by exogenously pro-
duced cGK IK in vivo. These observations showed that cGK
IK (I63T) is constitutively active not only in vitro but in intact
cells, suggesting the availability of this mutant as a tool for in
vivo analysis. Transgenic mouse expressing the constitutively
active form of cGK I will provide the important informations
for understanding of cGMP-mediated signaling pathways in
vivo.
4. Discussion
cGK IK and cGK IL contain a putative pseudosubstrate
site, 59RAQGISAEP and 74KRQAISAEP, within their auto-
inhibitory regions, respectively. The underlined amino acid is
thought to occupy the phosphate acceptor site (P0) according
to the consensus substrate sequence (RRXSX) in the type II
regulatory subunit (R subunit) of cAK. The pseudosubstrate
site is supposed to tightly interact with the catalytic site, and
inhibit the kinase activity in the absence of cGMP. The asso-
ciation of cGMP with cGMP-binding domains of cGK Is is
suggested to relieve autoinhibition of the catalytic site. Pre-
vious studies have demonstrated that the binding of cGMP
resulted in a conformational change in cGK Is [15,16]. The
binding of cGMP to cGK IK or cGK IL caused a large elec-
tronegative charge shift of the enzyme on ion exchange chro-
matography. Additionally, in cGK IL, activation by cGMP
decreased mobility on native gel electrophoresis. As noted
also, a previous report has suggested that enhanced proteol-
ysis within and near the pseudosubstrate site by cGMP is due
to increased solvent exposure of the autoinhibitory region in
the presence of cGMP. A basic residue, Arg-75 located at the
P32 position, is known to play an important role in the close
interaction between the autoinhibitory sequence and catalytic
domain in the inactive cGK IL [9]. In fact, replacement of
Arg-75 by Ala generates strong basal kinase activity [11].
The current study indicated that the hydrophobic residue at
the P+1 position is also a critical determinant for potent auto-
inhibition of catalysis and autophosphorylation of cGK Is in
the absence of cGMP. Our results with cGK Is may be appli-
cable to cGK II, because the hydrophobic residue (Ile or Val)
at the P+1 position is well conserved among cGKs. The e¡ect
of the hydrophobicity of the pseudosubstrate sequence on the
inhibition of kinase activity was previously tested using syn-
thetic peptides. The heat-stable inhibitor protein of cAK
(PKI) is a potent, competitive inhibitor of the catalytic sub-
unit of this enzyme, and contains a pseudosubstrate sequence.
The structure of the cAK catalytic subunit (C subunit) co-
Fig. 2. Phosphorylation of cTnI by cGK IL in vitro. COS-7 cells
were transfected with expression plasmid for FLAG-cTnI. Where in-
dicated, plasmid expressing either FLAG-cGK IL or FLAG-cGK IL
(I78G) was included in the transfection. Whole cell lysates were im-
munoprecipitated with anti-FLAG antibody (IP: Flag), and cGK
activity was measured in an in vitro kinase assay. Reactions were
performed in the absence (3) or presence (+) of 5 WM cGMP. To
monitor the expression level of each kinase, the immunoprecipitates
were blotted with anti-FLAG antibody (Blot: Flag).
Fig. 3. Phosphorylation of cTnI by cGK IK in vivo. COS-7 cells
were co-transfected with expression vectors for either FLAG-cGK
IK, FLAG-cGK IK (I63T) or kinase-defective mutant of FLAG-
cGK IK (cGK IK D501A) in combination with the expression plas-
mid for FLAG-cTnI. Cells were labeled with 32P as detailed under
Section 2. 32P-labeled cell lysates were immunoprecipitated with
anti-FLAG antibody (IP: Flag), and the immunoprecipitates were
subjected to SDS^PAGE and autoradiography. To monitor the ex-
pression levels of kinase and cTnI proteins, the immunoprecipitates
were blotted with anti-FLAG antibody (Blot: Flag).
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crystallized with PKI has demonstrated that Leu-24 at the
P+1 position in PKI stably associates with the hydrophobic
pocket formed by Leu-198, Pro-202 and Leu-205 in the C
subunit [17]. In fact, a previous report showed that substitu-
tion at the P+1 position with Gly signi¢cantly increased the Ki
value from 3 nM to 420 nM, indicating that Leu-24 is impor-
tant for the high-a⁄nity binding of the inhibitor peptide [18].
Additionally, a recent report on RI subunit of cAK demon-
strated that the inhibitory e¡ect was signi¢cantly reduced
when Ile-98 at the P+1 position was replaced by Ala [8]. These
observations strongly supported the importance of the hydro-
phobicity at the P+1 position of the pseudosubstrate sequence
in cGK Is for inhibition of basal kinase activity and of auto-
phosphorylation in the absence of cGMP.
As previously reported, autophosphorylation increased the
sensitivity of cGK IL to activation by cGMP [10]. In cGK IL,
the increase in basal kinase activity in the presence of cGMP
closely correlates with autophosphorylation at Ser-79. Also, a
recent report has shown that replacement of Ser-79 by an
acidic residue to mimic the e¡ect of autophosphorylation pro-
duces strong basal kinase activity [11]. However, in cGK IK,
autophosphorylation is observed at Thr-59, not at Ser-65
which corresponds to Ser-79 in cGK IL, when incubated in
the presence of cGMP. The constitutively active cGK IK de-
scribed in this study could enhance basal activity in the ab-
sence of cGMP, the e¡ect being accompanied by an increase
in the autophosphorylation. Further study is needed to deter-
mine the phosphorylated amino acids in this constitutively
active cGK IK, providing information about the mechanism
underlying activation of cGK IK.
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